Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-β-D-arabinofuranosylcytosine

M. G. Pallavicini, Joe Gray, L. J. Folstad

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Quantitative estimates of cytokinetic perturbations induced over a 30-hr interval in KHT tumor cells in vivo by a single dose of 1-β-D-arabinofuranosylcytosine (ara-C) were inferred from measurements of DNA distribution sequences, tritiated thymidine incorporation into tumor cell DNA, and radioactivity of cells labeled with tritiated thymidine prior to treatment with ara-C. These data were analyzed collectively to produce a mathematical model describing the effects of ara-C on tumor cell cycle kinetics. During analysis, we postulated that ara-C produced a transient block at the G1-S-phase boundary, that ara-C killed all cells in S phase, and that the cells killed by ara-C did not cycle after treatment. The analysis showed that the duration of the G1-S-boundary block was 5.5 hr, that cells were recruited from G0 into cycle beginning 5.5 hr posttreatment, and that the G1, S, and G2M phase durations of the clonogenic cells which were initially 2, 11.5, and 2 hr, respectively, changed to 0.8, 4.6, and 0.8 hr at 14 hr posttreatment. Cells killed by ara-C were removed from the tumor beginning 10 hr posttreatment. We then used the mathematical model to predict clonogenic tumor cell survival following a second dose of ara-C administered at time intervals from 1 to 30 hr after the first treatment. Clonogenic tumor cell survival following the second dose of ara-C was then experimentally determined and agreed well with the model predictions.

Original languageEnglish (US)
Pages (from-to)3125-3131
Number of pages7
JournalCancer Research
Volume42
Issue number8
StatePublished - 1982
Externally publishedYes

Fingerprint

Cytarabine
Neoplasms
S Phase
Thymidine
Cell Survival
Theoretical Models
G1 Phase
Radioactivity
Cell Cycle
DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-β-D-arabinofuranosylcytosine. / Pallavicini, M. G.; Gray, Joe; Folstad, L. J.

In: Cancer Research, Vol. 42, No. 8, 1982, p. 3125-3131.

Research output: Contribution to journalArticle

@article{d95fc6a39fb3407587c93da681b48bb4,
title = "Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-β-D-arabinofuranosylcytosine",
abstract = "Quantitative estimates of cytokinetic perturbations induced over a 30-hr interval in KHT tumor cells in vivo by a single dose of 1-β-D-arabinofuranosylcytosine (ara-C) were inferred from measurements of DNA distribution sequences, tritiated thymidine incorporation into tumor cell DNA, and radioactivity of cells labeled with tritiated thymidine prior to treatment with ara-C. These data were analyzed collectively to produce a mathematical model describing the effects of ara-C on tumor cell cycle kinetics. During analysis, we postulated that ara-C produced a transient block at the G1-S-phase boundary, that ara-C killed all cells in S phase, and that the cells killed by ara-C did not cycle after treatment. The analysis showed that the duration of the G1-S-boundary block was 5.5 hr, that cells were recruited from G0 into cycle beginning 5.5 hr posttreatment, and that the G1, S, and G2M phase durations of the clonogenic cells which were initially 2, 11.5, and 2 hr, respectively, changed to 0.8, 4.6, and 0.8 hr at 14 hr posttreatment. Cells killed by ara-C were removed from the tumor beginning 10 hr posttreatment. We then used the mathematical model to predict clonogenic tumor cell survival following a second dose of ara-C administered at time intervals from 1 to 30 hr after the first treatment. Clonogenic tumor cell survival following the second dose of ara-C was then experimentally determined and agreed well with the model predictions.",
author = "Pallavicini, {M. G.} and Joe Gray and Folstad, {L. J.}",
year = "1982",
language = "English (US)",
volume = "42",
pages = "3125--3131",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-β-D-arabinofuranosylcytosine

AU - Pallavicini, M. G.

AU - Gray, Joe

AU - Folstad, L. J.

PY - 1982

Y1 - 1982

N2 - Quantitative estimates of cytokinetic perturbations induced over a 30-hr interval in KHT tumor cells in vivo by a single dose of 1-β-D-arabinofuranosylcytosine (ara-C) were inferred from measurements of DNA distribution sequences, tritiated thymidine incorporation into tumor cell DNA, and radioactivity of cells labeled with tritiated thymidine prior to treatment with ara-C. These data were analyzed collectively to produce a mathematical model describing the effects of ara-C on tumor cell cycle kinetics. During analysis, we postulated that ara-C produced a transient block at the G1-S-phase boundary, that ara-C killed all cells in S phase, and that the cells killed by ara-C did not cycle after treatment. The analysis showed that the duration of the G1-S-boundary block was 5.5 hr, that cells were recruited from G0 into cycle beginning 5.5 hr posttreatment, and that the G1, S, and G2M phase durations of the clonogenic cells which were initially 2, 11.5, and 2 hr, respectively, changed to 0.8, 4.6, and 0.8 hr at 14 hr posttreatment. Cells killed by ara-C were removed from the tumor beginning 10 hr posttreatment. We then used the mathematical model to predict clonogenic tumor cell survival following a second dose of ara-C administered at time intervals from 1 to 30 hr after the first treatment. Clonogenic tumor cell survival following the second dose of ara-C was then experimentally determined and agreed well with the model predictions.

AB - Quantitative estimates of cytokinetic perturbations induced over a 30-hr interval in KHT tumor cells in vivo by a single dose of 1-β-D-arabinofuranosylcytosine (ara-C) were inferred from measurements of DNA distribution sequences, tritiated thymidine incorporation into tumor cell DNA, and radioactivity of cells labeled with tritiated thymidine prior to treatment with ara-C. These data were analyzed collectively to produce a mathematical model describing the effects of ara-C on tumor cell cycle kinetics. During analysis, we postulated that ara-C produced a transient block at the G1-S-phase boundary, that ara-C killed all cells in S phase, and that the cells killed by ara-C did not cycle after treatment. The analysis showed that the duration of the G1-S-boundary block was 5.5 hr, that cells were recruited from G0 into cycle beginning 5.5 hr posttreatment, and that the G1, S, and G2M phase durations of the clonogenic cells which were initially 2, 11.5, and 2 hr, respectively, changed to 0.8, 4.6, and 0.8 hr at 14 hr posttreatment. Cells killed by ara-C were removed from the tumor beginning 10 hr posttreatment. We then used the mathematical model to predict clonogenic tumor cell survival following a second dose of ara-C administered at time intervals from 1 to 30 hr after the first treatment. Clonogenic tumor cell survival following the second dose of ara-C was then experimentally determined and agreed well with the model predictions.

UR - http://www.scopus.com/inward/record.url?scp=0019953390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019953390&partnerID=8YFLogxK

M3 - Article

C2 - 7093956

AN - SCOPUS:0019953390

VL - 42

SP - 3125

EP - 3131

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 8

ER -